| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.758 | 0.009 | 0.758 | 15-Lipoxygenase inhibitor | 0.359 0.094 CID_59846969 | ||
| 0.742 | 0.005 | 0.742 | 12-Lipoxygenase inhibitor | 0.363 0.052 CID_59846969 | ||
| 0.745 | 0.018 | 0.745 | Caspase 9 stimulant | 0.552 0.044 CID_59846969 | ||
| 0.732 | 0.006 | 0.732 | Aldehyde oxidase inhibitor | 0.582 0.021 CID_59846969 | ||
| 0.691 | 0.006 | 0.691 | Antioxidant | 0.565 0.014 CID_59846969 | ||
| 0.675 | 0.035 | 0.837 | Apoptosis agonist | 0.837 0.012 CID_59846969 | CID_59846969 | |
| 0.647 | 0.007 | 0.647 | Lipoxygenase inhibitor | 0.336 0.055 CID_59846969 | ||
| 0.636 | 0.005 | 0.636 | GABA C receptor rho-3 antagonist | 0.584 0.009 CID_59846969 | ||
| 0.634 | 0.005 | 0.634 | Monophenol monooxygenase inhibitor | 0.347 0.014 CID_59846969 | ||
| 0.614 | 0.004 | 0.614 | Melanin inhibitor | 0.441 0.009 CID_59846969 | ||
| 0.64 | 0.043 | 0.64 | Antiinflammatory | 0.504 0.086 CID_59846969 | ||
| 0.6 | 0.008 | 0.6 | Free radical scavenger | 0.554 0.011 CID_59846969 | ||
| 0.589 | 0.003 | 0.589 | Cystathionine beta-synthase inhibitor | 0.363 0.006 CID_59846969 | ||
| 0.586 | 0.005 | 0.586 | Peroxidase inhibitor | 0.433 0.016 CID_59846969 | ||
| 0.588 | 0.011 | 0.588 | Caspase 3 stimulant | 0.493 0.021 CID_59846969 | ||
| 0.602 | 0.031 | 0.602 | Transcription factor NF kappa B inhibitor | 0.523 0.041 CID_59846969 | ||
| 0.544 | 0.005 | 0.544 | Topoisomerase II inhibitor | 0.145 0.052 CID_59846969 | ||
| 0.549 | 0.016 | 0.549 | Histamine release inhibitor | 0.377 0.087 CID_59846969 | ||
| 0.53 | 0.024 | 0.53 | 5 Hydroxytryptamine release inhibitor | 0.382 0.09 CID_59846969 | ||
| 0.51 | 0.011 | 0.51 | Vasodilator | 0.194 0.11 CID_59846969 | ||
| 0.461 | 0.003 | 0.461 | MAP kinase kinase 4 inhibitor | |||
| 0.463 | 0.005 | 0.463 | NOS3 expression enhancer | 0.175 0.053 CID_59846969 | ||
| 0.449 | 0.004 | 0.449 | Estrogen agonist | 0.26 0.006 CID_59846969 | ||
| 0.44 | 0.004 | 0.44 | Estrogen receptor beta antagonist | 0.343 0.005 CID_59846969 | ||
| 0.437 | 0.004 | 0.597 | Estrogen antagonist | 0.597 0.004 CID_59846969 | CID_59846969 | |
| 0.451 | 0.02 | 0.451 | Hypoxia-inducible factor 1 alpha inhibitor | 0.334 0.051 CID_59846969 | ||
| 0.431 | 0.004 | 0.431 | Topoisomerase II alpha inhibitor | 0.12 0.03 CID_59846969 | ||
| 0.42 | 0.023 | 0.425 | Nitric oxide antagonist | 0.425 0.023 CID_59846969 | CID_59846969 | |
| 0.412 | 0.026 | 0.412 | DNA damaging | |||
| 0.388 | 0.003 | 0.388 | Creatine kinase inhibitor | 0.208 0.009 CID_59846969 | ||
| 0.391 | 0.014 | 0.475 | Hepatoprotectant | 0.475 0.008 CID_59846969 | CID_59846969 | |
| 0.368 | 0.005 | 0.368 | Heat shock protein 90 antagonist | 0.134 0.092 CID_59846969 | ||
| 0.385 | 0.024 | 0.385 | Pyruvate kinase inhibitor | 0.269 0.056 CID_59846969 | ||
| 0.37 | 0.01 | 0.37 | Protein-tyrosine phosphatase inhibitor | 0.229 0.037 CID_59846969 | ||
| 0.423 | 0.067 | 0.423 | Antibacterial | 0.323 0.119 CID_59846969 | ||
| 0.381 | 0.031 | 0.381 | Hypoglycemic | 0.263 0.069 CID_59846969 | ||
| 0.352 | 0.005 | 0.352 | Nitric-oxide synthase stimulant | 0.249 0.033 CID_59846969 | ||
| 0.344 | 0.004 | 0.344 | Estrogen receptor alpha antagonist | 0.133 0.015 CID_59846969 | ||
| 0.347 | 0.008 | 0.347 | Protein-tyrosine phosphatase 1B inhibitor | 0.212 0.026 CID_59846969 | ||
| 0.332 | 0.005 | 0.332 | Aromatase inhibitor | 0.079 0.028 CID_59846969 | ||
| 0.336 | 0.008 | 0.336 | Topoisomerase I inhibitor | |||
| 0.352 | 0.034 | 0.352 | Amyloid beta aggregation inhibitor | 0.336 0.038 CID_59846969 | ||
| 0.322 | 0.016 | 0.322 | Amylase inhibitor | 0.317 0.016 CID_59846969 | ||
| 0.309 | 0.005 | 0.309 | Electron transport complex I inhibitor | 0.135 0.03 CID_59846969 | ||
| 0.321 | 0.018 | 0.321 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.223 0.056 CID_59846969 | ||
| 0.355 | 0.053 | 0.355 | Vasodilator, coronary | 0.243 0.141 CID_59846969 | ||
| 0.411 | 0.11 | 0.411 | Alpha-glucosidase inhibitor | 0.248 0.189 CID_59846969 | ||
| 0.336 | 0.042 | 0.336 | Antiamyloidogenic | |||
| 0.291 | 0.004 | 0.291 | Keratolytic | 0.168 0.012 CID_59846969 | ||
| 0.294 | 0.011 | 0.294 | 5-Lipoxygenase inhibitor | 0.251 0.016 CID_59846969 | ||
| 0.285 | 0.005 | 0.285 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.116 0.031 CID_59846969 | ||
| 0.294 | 0.013 | 0.294 | NADPH oxidase inhibitor | 0.193 0.036 CID_59846969 | ||
| 0.285 | 0.007 | 0.285 | GABA C receptor rho-2 antagonist | 0.219 0.02 CID_59846969 | ||
| 0.303 | 0.031 | 0.303 | RNA-directed DNA polymerase inhibitor | 0.221 0.072 CID_59846969 | ||
| 0.331 | 0.066 | 0.331 | Apoptosis antagonist | 0.28 0.1 CID_59846969 | ||
| 0.286 | 0.021 | 0.286 | Lipid peroxidase inhibitor | 0.195 0.044 CID_59846969 | ||
| 0.268 | 0.005 | 0.268 | CF transmembrane conductance regulator agonist | 0.196 0.024 CID_59846969 | ||
| 0.304 | 0.04 | 0.304 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.292 | 0.03 | 0.292 | P-glycoprotein inhibitor | 0.138 0.136 CID_59846969 | ||
| 0.276 | 0.015 | 0.348 | Succinate dehydrogenase inhibitor | 0.348 0.005 CID_59846969 | CID_59846969 | |
| 0.295 | 0.035 | 0.345 | Tyrosine 3 hydroxylase inhibitor | 0.345 0.017 CID_59846969 | CID_59846969 | |
| 0.346 | 0.089 | 0.346 | Immunosuppressant | |||
| 0.28 | 0.024 | 0.28 | Neurotrophic factor enhancer | 0.271 0.028 CID_59846969 | ||
| 0.271 | 0.015 | 0.271 | Aldehyde dehydrogenase inhibitor | 0.144 0.051 CID_59846969 | ||
| 0.258 | 0.004 | 0.258 | Estrogen receptor beta agonist | 0.178 0.005 CID_59846969 | ||
| 0.302 | 0.049 | 0.461 | Superoxide dismutase inhibitor | 0.461 0.017 CID_59846969 | CID_59846969 | |
| 0.298 | 0.046 | 0.479 | 5 Hydroxytryptamine uptake stimulant | 0.479 0.005 CID_59846969 | CID_59846969 | |
| 0.272 | 0.02 | 0.272 | Heat shock protein 90 alpha antagonist | 0.135 0.104 CID_59846969 | ||
| 0.271 | 0.024 | 0.3 | MAO inhibitor | 0.3 0.02 CID_59846969 | CID_59846969 | |
| 0.313 | 0.067 | 0.313 | Sodium/bile acid cotransporter inhibitor | 0.216 0.166 CID_59846969 | ||
| 0.254 | 0.013 | 0.254 | Interleukin 4 antagonist | 0.17 0.035 CID_59846969 | ||
| 0.236 | 0.01 | 0.236 | Histidine decarboxylase inhibitor | 0.158 0.018 CID_59846969 | ||
| 0.247 | 0.021 | 0.302 | MAO A inhibitor | 0.302 0.015 CID_59846969 | CID_59846969 | |
| 0.222 | 0.005 | 0.222 | DOPA decarboxylase inhibitor | 0.205 0.006 CID_59846969 | ||
| 0.283 | 0.075 | 0.307 | 5 Hydroxytryptamine release stimulant | 0.307 0.068 CID_59846969 | CID_59846969 | |
| 0.282 | 0.077 | 0.287 | Spasmolytic | 0.287 0.075 CID_59846969 | CID_59846969 | |
| 0.213 | 0.01 | 0.213 | GABA C receptor antagonist | 0.198 0.013 CID_59846969 | ||
| 0.336 | 0.133 | 0.336 | Cyclophilin D inhibitor | |||
| 0.216 | 0.014 | 0.216 | Carbonic anhydrase III inhibitor | 0.121 0.044 CID_59846969 | ||
| 0.332 | 0.131 | 0.332 | Calcium channel L-type activator | 0.253 0.202 CID_59846969 | ||
| 0.207 | 0.013 | 0.207 | Androgen antagonist | 0.115 0.036 CID_59846969 | ||
| 0.214 | 0.022 | 0.249 | MAO B inhibitor | 0.249 0.017 CID_59846969 | CID_59846969 | |
| 0.22 | 0.028 | 0.22 | Acetylcholinesterase inhibitor | |||
| 0.289 | 0.098 | 0.292 | Cholesterol antagonist | 0.292 0.096 CID_59846969 | CID_59846969 | |
| 0.203 | 0.018 | 0.203 | Carbonic anhydrase XV inhibitor | 0.124 0.044 CID_59846969 | ||
| 0.203 | 0.019 | 0.206 | Xanthine oxidase inhibitor | 0.206 0.018 CID_59846969 | CID_59846969 | |
| 0.187 | 0.005 | 0.187 | Ornithine decarboxylase inhibitor | 0.115 0.03 CID_59846969 | ||
| 0.26 | 0.08 | 0.519 | Transcription factor STAT inhibitor | 0.519 0.007 CID_59846969 | CID_59846969 | |
| 0.249 | 0.07 | 0.306 | Angiogenesis stimulant | 0.306 0.047 CID_59846969 | CID_59846969 | |
| 0.199 | 0.022 | 0.199 | Farnesoid X receptor antagonist | 0.154 0.048 CID_59846969 | ||
| 0.186 | 0.014 | 0.207 | Beta glucuronidase inhibitor | 0.207 0.012 CID_59846969 | CID_59846969 | |
| 0.181 | 0.013 | 0.181 | Prolactin inhibitor | 0.122 0.037 CID_59846969 | ||
| 0.167 | 0.005 | 0.167 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.109 0.014 CID_59846969 | ||
| 0.2 | 0.041 | 0.203 | Interferon gamma antagonist | 0.203 0.04 CID_59846969 | CID_59846969 | |
| 0.198 | 0.042 | 0.226 | Protein kinase stimulant | 0.226 0.033 CID_59846969 | CID_59846969 | |
| 0.173 | 0.017 | 0.173 | Uric acid excretion stimulant | |||
| 0.207 | 0.052 | 0.207 | Lipocortins synthesis antagonist | |||
| 0.166 | 0.015 | 0.166 | GABA C receptor rho-1 antagonist | 0.144 0.024 CID_59846969 | ||
| 0.159 | 0.01 | 0.159 | Aldose reductase inhibitor | |||
| 0.18 | 0.032 | 0.18 | Cholesterol synthesis inhibitor | 0.142 0.049 CID_59846969 | ||
| 0.25 | 0.103 | 0.25 | Streptokinase A inhibitor | 0.245 0.106 CID_59846969 | ||
| 0.266 | 0.119 | 0.266 | Prostaglandin dehydrogenase inhibitor | |||
| 0.156 | 0.013 | 0.16 | HIV-1 integrase (3'-Processing) inhibitor | 0.16 0.012 CID_59846969 | CID_59846969 | |
| 0.233 | 0.093 | 0.233 | 5 Hydroxytryptamine 1E antagonist | 0.179 0.155 CID_59846969 | ||
| 0.144 | 0.005 | 0.144 | Fatty acid synthase inhibitor | 0.066 0.029 CID_59846969 | ||
| 0.181 | 0.044 | 0.277 | Tubulin antagonist | 0.277 0.022 CID_59846969 | CID_59846969 | |
| 0.21 | 0.074 | 0.21 | Psychostimulant | 0.153 0.113 CID_59846969 | ||
| 0.157 | 0.021 | 0.356 | Breast cancer-resistant protein inhibitor | 0.356 0.006 CID_59846969 | CID_59846969 | |
| 0.176 | 0.041 | 0.176 | M18 aspartyl aminopeptidase inhibitor | 0.118 0.072 CID_59846969 | ||
| 0.223 | 0.091 | 0.223 | DNA synthesis inhibitor | 0.219 0.096 CID_59846969 | ||
| 0.183 | 0.051 | 0.205 | Arachidonic acid antagonist | 0.205 0.029 CID_59846969 | CID_59846969 | |
| 0.158 | 0.028 | 0.18 | Papain-like protease (SARS coronavirus) inhibitor | 0.18 0.016 CID_59846969 | CID_59846969 | |
| 0.166 | 0.036 | 0.166 | Cyclooxygenase 3 inhibitor | 0.126 0.071 CID_59846969 | ||
| 0.149 | 0.02 | 0.149 | Telomerase inhibitor | |||
| 0.153 | 0.024 | 0.153 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.135 | 0.007 | 0.135 | Estradiol 17 beta-dehydrogenase inhibitor | 0.063 0.018 CID_59846969 | ||
| 0.148 | 0.021 | 0.148 | Carbonic anhydrase VI inhibitor | |||
| 0.131 | 0.005 | 0.131 | Heat shock protein 90 beta antagonist | |||
| 0.181 | 0.056 | 0.181 | Cholinergic | |||
| 0.155 | 0.034 | 0.155 | Chelator | 0.122 0.052 CID_59846969 | ||
| 0.156 | 0.035 | 0.156 | Heat shock protein 70 antagonist | 0.152 0.041 CID_59846969 | ||
| 0.159 | 0.039 | 0.159 | DNA intercalator | |||
| 0.224 | 0.107 | 0.499 | Transcription factor STAT3 inhibitor | 0.499 0.007 CID_59846969 | CID_59846969 | |
| 0.126 | 0.011 | 0.131 | D-Ala-D-Ala ligase inhibitor | 0.131 0.009 CID_59846969 | CID_59846969 | |
| 0.129 | 0.014 | 0.129 | Histone deacetylase stimulant | |||
| 0.129 | 0.014 | 0.129 | Histone deacetylase SIRT1 stimulant | |||
| 0.255 | 0.141 | 0.292 | Calcium channel activator | 0.292 0.099 CID_59846969 | CID_59846969 | |
| 0.139 | 0.025 | 0.165 | Anabolic | 0.165 0.011 CID_59846969 | CID_59846969 | |
| 0.141 | 0.028 | 0.141 | Urease inhibitor | 0.086 0.083 CID_59846969 | ||
| 0.151 | 0.039 | 0.16 | Ca2+-transporting ATPase inhibitor | 0.16 0.024 CID_59846969 | CID_59846969 | |
| 0.19 | 0.079 | 0.203 | Non-steroidal antiinflammatory agent | 0.203 0.068 CID_59846969 | CID_59846969 | |
| 0.155 | 0.044 | 0.155 | Alkylator | |||
| 0.136 | 0.026 | 0.136 | Alcohol dehydrogenase inhibitor | 0.087 0.069 CID_59846969 | ||
| 0.21 | 0.1 | 0.21 | Tumour necrosis factor alpha release inhibitor | |||
| 0.124 | 0.016 | 0.124 | Lipase inhibitor | 0.106 0.024 CID_59846969 | ||
| 0.144 | 0.037 | 0.144 | DNA repair enzyme inhibitor | |||
| 0.158 | 0.051 | 0.184 | Adenylate cyclase stimulant | 0.184 0.023 CID_59846969 | CID_59846969 | |
| 0.113 | 0.007 | 0.143 | Estrogen receptor alpha agonist | 0.143 0.005 CID_59846969 | CID_59846969 | |
| 0.155 | 0.049 | 0.155 | Toll-Like receptor 2 antagonist | 0.142 0.059 CID_59846969 | ||
| 0.116 | 0.013 | 0.116 | Alpha tubulin antagonist | 0.063 0.029 CID_59846969 | ||
| 0.182 | 0.081 | 0.182 | Platelet adhesion inhibitor | |||
| 0.135 | 0.035 | 0.135 | Antineoplastic antibiotic | 0.078 0.058 CID_59846969 | ||
| 0.124 | 0.024 | 0.124 | Macrophage migration inhibitory factor inhibitor | 0.12 0.025 CID_59846969 | ||
| 0.116 | 0.018 | 0.139 | HIV-1 integrase (Strand Transfer) inhibitor | 0.139 0.014 CID_59846969 | CID_59846969 | |
| 0.151 | 0.056 | 0.175 | Cyclooxygenase 1 inhibitor | 0.175 0.045 CID_59846969 | CID_59846969 | |
| 0.197 | 0.104 | 0.197 | Aryl hydrocarbon receptor agonist | |||
| 0.128 | 0.035 | 0.18 | HIV-1 integrase (Overall Integration) inhibitor | 0.18 0.016 CID_59846969 | CID_59846969 | |
| 0.216 | 0.124 | 0.216 | Gastrin inhibitor | |||
| 0.095 | 0.003 | 0.109 | Estrogen-related receptor beta antagonist | 0.109 0.002 CID_59846969 | CID_59846969 | |
| 0.134 | 0.042 | 0.161 | Photosensitizer | 0.161 0.025 CID_59846969 | CID_59846969 | |
| 0.11 | 0.02 | 0.11 | HIV-1 integrase inhibitor | 0.099 0.025 CID_59846969 | ||
| 0.119 | 0.03 | 0.119 | Carbonic anhydrase XIII inhibitor | 0.093 0.041 CID_59846969 | ||
| 0.138 | 0.05 | 0.138 | Beta amyloid protein antagonist | |||
| 0.115 | 0.027 | 0.122 | Interleukin 5 antagonist | 0.122 0.023 CID_59846969 | CID_59846969 | |
| 0.11 | 0.023 | 0.11 | Na+ K+ transporting ATPase inhibitor | 0.093 0.038 CID_59846969 | ||
| 0.182 | 0.095 | 0.208 | Antimitotic | 0.208 0.079 CID_59846969 | CID_59846969 | |
| 0.095 | 0.01 | 0.095 | Topoisomerase II beta inhibitor | |||
| 0.165 | 0.08 | 0.195 | Phospholipase C inhibitor | 0.195 0.048 CID_59846969 | CID_59846969 | |
| 0.128 | 0.044 | 0.128 | Alpha 2c adrenoreceptor antagonist | |||
| 0.163 | 0.081 | 0.163 | Dual specificity phosphatase inhibitor | |||
| 0.115 | 0.034 | 0.115 | Interleukin 12 antagonist | |||
| 0.103 | 0.026 | 0.103 | Thioredoxin reductase inhibitor | 0.084 0.052 CID_59846969 | ||
| 0.104 | 0.027 | 0.104 | Cyclin B3 inhibitor | |||
| 0.122 | 0.045 | 0.122 | Mediator release inhibitor | |||
| 0.082 | 0.006 | 0.082 | Dopamine D5 agonist | 0.06 0.012 CID_59846969 | ||
| 0.135 | 0.058 | 0.135 | DNA polymerase I inhibitor | |||
| 0.098 | 0.023 | 0.098 | Beta tubulin antagonist | 0.084 0.028 CID_59846969 | ||
| 0.091 | 0.019 | 0.091 | Xanthine dehydrogenase inhibitor | 0.071 0.03 CID_59846969 | ||
| 0.09 | 0.019 | 0.09 | Neuraminidase inhibitor | 0.059 0.044 CID_59846969 | ||
| 0.123 | 0.052 | 0.162 | Mucolytic | 0.162 0.026 CID_59846969 | CID_59846969 | |
| 0.124 | 0.053 | 0.124 | Transcription factor STAT6 inhibitor | 0.116 0.067 CID_59846969 | ||
| 0.109 | 0.039 | 0.12 | Thioredoxin inhibitor | 0.12 0.03 CID_59846969 | CID_59846969 | |
| 0.106 | 0.037 | 0.106 | Bile acid receptor antagonist | 0.104 0.04 CID_59846969 | ||
| 0.119 | 0.05 | 0.119 | AMP-activated protein kinase stimulant | |||
| 0.172 | 0.104 | 0.205 | Insulin sensitizer | 0.205 0.068 CID_59846969 | CID_59846969 | |
| 0.124 | 0.056 | 0.124 | Microtubule formation inhibitor | 0.1 0.09 CID_59846969 | ||
| 0.22 | 0.154 | 0.248 | Vasodilator, peripheral | 0.248 0.129 CID_59846969 | CID_59846969 | |
| 0.136 | 0.071 | 0.165 | Alkaline phosphatase inhibitor | 0.165 0.051 CID_59846969 | CID_59846969 | |
| 0.079 | 0.018 | 0.086 | Transcription factor RelA inhibitor | 0.086 0.013 CID_59846969 | CID_59846969 | |
| 0.069 | 0.009 | 0.069 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.046 0.018 CID_59846969 | ||
| 0.083 | 0.024 | 0.083 | Glutamate (mGluR7) antagonist | |||
| 0.093 | 0.035 | 0.117 | Estrogen-related receptor beta agonist | 0.117 0.011 CID_59846969 | CID_59846969 | |
| 0.118 | 0.061 | 0.217 | TRPA1 agonist | 0.217 0.008 CID_59846969 | CID_59846969 | |
| 0.139 | 0.082 | 0.139 | Hemostatic | |||
| 0.074 | 0.019 | 0.097 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.097 0.011 CID_59846969 | CID_59846969 | |
| 0.096 | 0.04 | 0.096 | Myeloperoxidase inhibitor | |||
| 0.102 | 0.047 | 0.102 | ABCA1 expression enhancer | |||
| 0.173 | 0.119 | 0.174 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.174 0.118 CID_59846969 | CID_59846969 | |
| 0.149 | 0.097 | 0.149 | Dual specificity phosphatase 3 inhibitor | |||
| 0.077 | 0.025 | 0.077 | Androgen agonist | 0.067 0.033 CID_59846969 | ||
| 0.105 | 0.055 | 0.2 | UDP-glucose 4-epimerase inhibitor | 0.2 0.018 CID_59846969 | CID_59846969 | |
| 0.144 | 0.095 | 0.144 | Mcl-1 antagonist | |||
| 0.123 | 0.074 | 0.234 | Alpha-N-acetylglucosaminidase inhibitor | 0.234 0.026 CID_59846969 | CID_59846969 | |
| 0.15 | 0.102 | 0.179 | Neurotensin receptor agonist | 0.179 0.051 CID_59846969 | CID_59846969 | |
| 0.102 | 0.057 | 0.102 | Sphingomyelinase inhibitor | |||
| 0.058 | 0.014 | 0.058 | GABA B receptor antagonist | |||
| 0.06 | 0.017 | 0.06 | Cholesterol esterase inhibitor | |||
| 0.07 | 0.029 | 0.126 | Alcohol oxidase inhibitor | 0.126 0.013 CID_59846969 | CID_59846969 | |
| 0.073 | 0.034 | 0.073 | Glutamate (mGluR6) antagonist | 0.062 0.06 CID_59846969 | ||
| 0.111 | 0.073 | 0.127 | Proteasome inhibitor | 0.127 0.06 CID_59846969 | CID_59846969 | |
| 0.073 | 0.034 | 0.073 | Aryl hydrocarbon receptor antagonist | |||
| 0.059 | 0.022 | 0.091 | Potassium channel Kv1.3 blocker | 0.091 0.01 CID_59846969 | CID_59846969 | |
| 0.051 | 0.014 | 0.051 | Arginase inhibitor | |||
| 0.102 | 0.066 | 0.141 | Expectorant | 0.141 0.039 CID_59846969 | CID_59846969 | |
| 0.08 | 0.045 | 0.097 | MAP kinase kinase 7 inhibitor | 0.097 0.016 CID_59846969 | CID_59846969 | |
| 0.126 | 0.092 | 0.274 | Cyclooxygenase inhibitor | 0.274 0.022 CID_59846969 | CID_59846969 | |
| 0.07 | 0.036 | 0.07 | Neuraminidase (influenza) inhibitor | 0.063 0.046 CID_59846969 | ||
| 0.09 | 0.056 | 0.111 | NADH dehydrogenase inhibitor | 0.111 0.034 CID_59846969 | CID_59846969 | |
| 0.056 | 0.022 | 0.056 | Carbonic anhydrase VII inhibitor | |||
| 0.089 | 0.055 | 0.089 | NMDA receptor antagonist | |||
| 0.04 | 0.008 | 0.04 | Sodium/glucose cotransporter 2 inhibitor | 0.031 0.012 CID_59846969 | ||
| 0.077 | 0.047 | 0.202 | Glutamate decarboxylase inhibitor | 0.202 0.007 CID_59846969 | CID_59846969 | |
| 0.049 | 0.019 | 0.049 | DNA gyrase subunit A inhibitor | |||
| 0.049 | 0.019 | 0.049 | 5-Alpha-reductase inhibitor | 0.04 0.024 CID_59846969 | ||
| 0.039 | 0.009 | 0.039 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.026 0.013 CID_59846969 | ||
| 0.069 | 0.04 | 0.069 | Dopamine D1 antagonist | |||
| 0.092 | 0.062 | 0.092 | Protein kinase C zeta inhibitor | |||
| 0.076 | 0.048 | 0.095 | CDC25A inhibitor | 0.095 0.031 CID_59846969 | CID_59846969 | |
| 0.067 | 0.04 | 0.067 | 5 Hydroxytryptamine 2A agonist | |||
| 0.074 | 0.047 | 0.087 | Glycine receptor agonist | 0.087 0.031 CID_59846969 | CID_59846969 | |
| 0.058 | 0.031 | 0.058 | Thromboxane synthase inhibitor | |||
| 0.04 | 0.013 | 0.04 | ATP citrate lysase inhibitor | 0.029 0.026 CID_59846969 | ||
| 0.058 | 0.033 | 0.059 | Leukotriene C antagonist | 0.059 0.03 CID_59846969 | CID_59846969 | |
| 0.057 | 0.032 | 0.061 | Leukotriene B4 antagonist | 0.061 0.026 CID_59846969 | CID_59846969 | |
| 0.122 | 0.098 | 0.13 | Mannose-6-phosphate isomerase inhibitor | 0.13 0.086 CID_59846969 | CID_59846969 | |
| 0.114 | 0.091 | 0.134 | Bone formation stimulant | 0.134 0.073 CID_59846969 | CID_59846969 | |
| 0.032 | 0.01 | 0.032 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 CID_59846969 | ||
| 0.049 | 0.027 | 0.049 | Adenylate cyclase 1 inhibitor | 0.046 0.032 CID_59846969 | ||
| 0.083 | 0.061 | 0.083 | mTOR complex 2 inhibitor | |||
| 0.054 | 0.032 | 0.054 | Glucose-6-phosphate translocase inhibitor | |||
| 0.056 | 0.037 | 0.056 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.072 | 0.052 | 0.072 | Dopamine antagonist | |||
| 0.037 | 0.018 | 0.037 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.135 | 0.115 | 0.153 | Interleukin 6 antagonist | 0.153 0.085 CID_59846969 | CID_59846969 | |
| 0.127 | 0.108 | 0.214 | Hexokinase inhibitor | 0.214 0.028 CID_59846969 | CID_59846969 | |
| 0.08 | 0.061 | 0.127 | Ca(v)3.1 blocker | 0.127 0.009 CID_59846969 | CID_59846969 | |
| 0.153 | 0.136 | 0.258 | Growth factor agonist | 0.258 0.028 CID_59846969 | CID_59846969 | |
| 0.06 | 0.045 | 0.06 | NMDA 2C receptor antagonist | |||
| 0.062 | 0.048 | 0.062 | Dopamine D2 antagonist | |||
| 0.064 | 0.05 | 0.064 | Leukotriene synthesis inhibitor | |||
| 0.035 | 0.021 | 0.035 | Estrogen-related receptor alpha antagonist | 0.032 0.024 CID_59846969 | ||
| 0.06 | 0.046 | 0.06 | Heme oxygenase stimulant | |||
| 0.018 | 0.005 | 0.018 | Antibiotic Tetracycline-like | 0.015 0.012 CID_59846969 | ||
| 0.06 | 0.047 | 0.06 | Protease activated receptor antagonist | |||
| 0.019 | 0.007 | 0.019 | NMDA receptor phencyclidine site antagonist | |||
| 0.093 | 0.081 | 0.132 | Adenylate kinase inhibitor | 0.132 0.035 CID_59846969 | CID_59846969 | |
| 0.083 | 0.071 | 0.158 | Triose-phosphate isomerase inhibitor | 0.158 0.018 CID_59846969 | CID_59846969 | |
| 0.061 | 0.05 | 0.081 | Leukotriene antagonist | 0.081 0.031 CID_59846969 | CID_59846969 | |
| 0.046 | 0.036 | 0.054 | Glucose-6-phosphate isomerase inhibitor | 0.054 0.025 CID_59846969 | CID_59846969 | |
| 0.109 | 0.099 | 0.109 | Antibacterial (Helicobacter pylori) | |||
| 0.106 | 0.096 | 0.225 | Cyclooxygenase 2 inhibitor | 0.225 0.025 CID_59846969 | CID_59846969 | |
| 0.063 | 0.053 | 0.146 | Phosphofructokinase-1 inhibitor | 0.146 0.019 CID_59846969 | CID_59846969 | |
| 0.023 | 0.015 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.013 CID_59846969 | CID_59846969 | |
| 0.121 | 0.115 | 0.159 | Phospholipase A2 inhibitor | 0.159 0.066 CID_59846969 | CID_59846969 | |
| 0.113 | 0.107 | 0.161 | Vanilloid 1 agonist | 0.161 0.029 CID_59846969 | CID_59846969 | |
| 0.055 | 0.049 | 0.055 | Sphingosine kinase inhibitor | |||
| 0.088 | 0.082 | 0.166 | GABA C receptor agonist | 0.166 0.029 CID_59846969 | CID_59846969 | |
| 0.022 | 0.018 | 0.022 | Dopamine autoreceptor agonist | |||
| 0.061 | 0.057 | 0.061 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.053 | 0.049 | 0.053 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.061 | 0.058 | 0.061 | Carbonic anhydrase VA inhibitor | |||
| 0.034 | 0.031 | 0.034 | NMDA receptor subunit 3A antagonist | |||
| 0.031 | 0.029 | 0.031 | Protein kinase (CK2) beta inhibitor | |||
| 0.02 | 0.018 | 0.025 | Leukotriene B4 receptor 2 antagonist | 0.025 0.012 CID_59846969 | CID_59846969 | |
| 0.034 | 0.033 | 0.034 | Delayed rectifier potassium channel blocker | |||
| 0.017 | 0.021 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 CID_59846969 | CID_59846969 | |
| 0.066 | 0.07 | 0.111 | GABA aminotransferase inhibitor | 0.111 0.02 CID_59846969 | CID_59846969 | |
| 0.149 | 0.156 | 0.205 | Immunostimulant | 0.205 0.117 CID_59846969 | CID_59846969 | |
| 0.181 | 0.189 | 0.252 | Insulysin inhibitor | 0.252 0.094 CID_59846969 | CID_59846969 | |
| 0.021 | 0.03 | 0.032 | Vanilloid 2 agonist | 0.032 0.008 CID_59846969 | CID_59846969 | |
| 0.043 | 0.054 | 0.054 | CD45 antagonist | 0.054 0.029 CID_59846969 | CID_59846969 | |
| 0.13 | 0.144 | 0.161 | I kappa B kinase epsilon inhibitor | 0.161 0.108 CID_59846969 | CID_59846969 | |
| 0.034 | 0.048 | 0.038 | Leukotriene C4 antagonist | 0.038 0.029 CID_59846969 | CID_59846969 | |
| 0.027 | 0.042 | 0.034 | Glutamate (mGluR3) agonist | 0.034 0.019 CID_59846969 | CID_59846969 | |
| 0.017 | 0.035 | 0.034 | Leukotriene B4 receptor 1 antagonist | 0.034 0.015 CID_59846969 | CID_59846969 | |
| 0.067 | 0.09 | 0.157 | Glutathione S-transferase inhibitor | 0.157 0.01 CID_59846969 | CID_59846969 | |
| 0.051 | 0.073 | 0.151 | Phenylalanine 4-hydroxylase inhibitor | 0.151 0.012 CID_59846969 | CID_59846969 | |
| 0.03 | 0.053 | 0.041 | Glutamate (mGluR8) agonist | 0.041 0.021 CID_59846969 | CID_59846969 | |
| 0.053 | 0.078 | 0.246 | Porphobilinogen synthase inhibitor | 0.246 0.008 CID_59846969 | CID_59846969 | |
| 0.033 | 0.06 | 0.054 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.054 0.011 CID_59846969 | CID_59846969 | |
| 0.019 | 0.049 | 0.036 | Retinoid X receptor agonist | 0.036 0.025 CID_59846969 | CID_59846969 | |
| 0.038 | 0.069 | 0.065 | Dopamine beta hydroxylase inhibitor | 0.065 0.01 CID_59846969 | CID_59846969 | |
| 0.055 | 0.087 | 0.098 | Glutamate dehydrogenase inhibitor | 0.098 0.032 CID_59846969 | CID_59846969 | |
| 0.038 | 0.07 | 0.056 | Aconitate hydratase inhibitor | 0.056 0.03 CID_59846969 | CID_59846969 | |
| 0.071 | 0.106 | 0.095 | Granulocyte macrophage colony stimulating factor agonist | 0.095 0.042 CID_59846969 | CID_59846969 | |
| 0.027 | 0.063 | 0.045 | Retinoid X receptor antagonist | 0.045 0.017 CID_59846969 | CID_59846969 | |
| 0.027 | 0.064 | 0.043 | Retinoic acid alpha receptor agonist | 0.043 0.021 CID_59846969 | CID_59846969 | |
| 0.042 | 0.082 | 0.078 | Dihydroorotate oxidase inhibitor | 0.078 0.011 CID_59846969 | CID_59846969 | |
| 0.02 | 0.061 | 0.037 | Estrogen-related receptor gamma antagonist | 0.037 0.007 CID_59846969 | CID_59846969 | |
| 0.067 | 0.113 | 0.152 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.152 0.026 CID_59846969 | CID_59846969 | |
| 0.014 | 0.064 | 0.025 | Retinoic acid gamma receptor agonist | 0.025 0.01 CID_59846969 | CID_59846969 | |
| 0.047 | 0.098 | 0.06 | Ryanodine receptor antagonist | 0.06 0.036 CID_59846969 | CID_59846969 | |
| 0.036 | 0.087 | 0.068 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.068 0.027 CID_59846969 | CID_59846969 | |
| 0.06 | 0.113 | 0.084 | GABA B receptor agonist | 0.084 0.035 CID_59846969 | CID_59846969 | |
| 0.041 | 0.096 | 0.084 | Purinergic P2X1 antagonist | 0.084 0.023 CID_59846969 | CID_59846969 | |
| 0.01 | 0.067 | 0.021 | Estrogen-related receptor gamma agonist | 0.021 0.009 CID_59846969 | CID_59846969 | |
| 0.035 | 0.091 | 0.058 | Carbamoyl phosphate synthetase inhibitor | 0.058 0.045 CID_59846969 | CID_59846969 | |
| 0.055 | 0.115 | 0.083 | Glycine receptor antagonist | 0.083 0.052 CID_59846969 | CID_59846969 | |
| 0.048 | 0.109 | 0.079 | CYP2A6 inhibitor | 0.079 0.049 CID_59846969 | CID_59846969 | |
| 0.031 | 0.092 | 0.052 | Argininosuccinate synthase inhibitor | 0.052 0.044 CID_59846969 | CID_59846969 | |
| 0.093 | 0.155 | 0.145 | Cell wall synthesis inhibitor | 0.145 0.07 CID_59846969 | CID_59846969 | |
| 0.022 | 0.086 | 0.039 | GABA uptake inhibitor | 0.039 0.027 CID_59846969 | CID_59846969 | |
| 0.033 | 0.101 | 0.057 | TRPA1 antagonist | 0.057 0.048 CID_59846969 | CID_59846969 | |
| 0.021 | 0.09 | 0.038 | Retinoid X alpha receptor antagonist | 0.038 0.018 CID_59846969 | CID_59846969 | |
| 0.035 | 0.104 | 0.052 | Sphingosine kinase 2 inhibitor | 0.052 0.043 CID_59846969 | CID_59846969 | |
| 0.106 | 0.178 | 0.349 | Interleukin antagonist | 0.349 0.039 CID_59846969 | CID_59846969 | |
| 0.028 | 0.102 | 0.05 | Kainate receptor agonist | 0.05 0.014 CID_59846969 | CID_59846969 | |
| 0.042 | 0.119 | 0.067 | Aminopeptidase I inhibitor | 0.067 0.057 CID_59846969 | CID_59846969 | |
| 0.048 | 0.128 | 0.087 | Potassium channel (Ca-activated) activator | 0.087 0.068 CID_59846969 | CID_59846969 | |
| 0.068 | 0.158 | 0.092 | Toll-Like receptor 4 antagonist | 0.092 0.086 CID_59846969 | CID_59846969 | |
| 0.024 | 0.118 | 0.062 | Acyl-CoA dehydrogenase inhibitor | 0.062 0.031 CID_59846969 | CID_59846969 | |
| 0.093 | 0.194 | 0.198 | Anesthetic general | 0.198 0.075 CID_59846969 | CID_59846969 | |
| 0.059 | 0.159 | 0.087 | Lanosterol 14 alpha demethylase inhibitor | 0.087 0.077 CID_59846969 | CID_59846969 | |
| 0.067 | 0.17 | 0.088 | Phosphodiesterase 6D inhibitor | 0.088 0.081 CID_59846969 | CID_59846969 | |
| 0.04 | 0.152 | 0.083 | Potassium channel large-conductance Ca-activated activator | 0.083 0.033 CID_59846969 | CID_59846969 | |
| 0.047 | 0.161 | 0.074 | Inducible nitric-oxide synthase inhibitor | 0.074 0.072 CID_59846969 | CID_59846969 | |
| 0.025 | 0.142 | 0.096 | Biliverdin reductase inhibitor | 0.096 0.02 CID_59846969 | CID_59846969 | |
| 0.014 | 0.156 | 0.046 | Ornithine carbamoyltransferase inhibitor | 0.046 0.043 CID_59846969 | CID_59846969 | |
| 0.011 | 0.165 | 0.04 | Dihydropteroate synthase inhibitor | 0.04 0.026 CID_59846969 | CID_59846969 | |
| 0.059 | 0.214 | 0.081 | CC chemokine 5 receptor agonist | 0.081 0.061 CID_59846969 | CID_59846969 | |
| 0.077 | 0.254 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | 0.121 0.093 CID_59846969 | CID_59846969 | |
| 0.129 | 0.315 | 0.378 | Transcription factor inhibitor | 0.378 0.118 CID_59846969 | CID_59846969 | |
| 0.028 | 0.232 | 0.069 | Factor III inhibitor | 0.069 0.011 CID_59846969 | CID_59846969 | |
| 0.049 | 0.26 | 0.239 | Vanilloid agonist | 0.239 0.005 CID_59846969 | CID_59846969 | |
| 0.045 | 0.258 | 0.107 | Electrolyte absorption antagonist | 0.107 0.048 CID_59846969 | CID_59846969 | |
| 0.037 | 0.258 | 0.168 | Ferrochelatase inhibitor | 0.168 0.031 CID_59846969 | CID_59846969 | |
| 0.023 | 0.252 | 0.102 | Anesthetic local | 0.102 0.081 CID_59846969 | CID_59846969 | |
| 0.03 | 0.3 | 0.085 | Exportin-1 inhibitor | 0.085 0.02 CID_59846969 | CID_59846969 | |
| 0.065 | 0.344 | 0.194 | Growth hormone agonist | 0.194 0.061 CID_59846969 | CID_59846969 | |
| 0.042 | 0.326 | 0.085 | Transcription factor NF kappa B stimulant | 0.085 0.059 CID_59846969 | CID_59846969 | |
| 0.038 | 0.343 | 0.326 | Interleukin 1b antagonist | 0.326 0.008 CID_59846969 | CID_59846969 | |
| 0.003 | 0.319 | 0.013 | Calcium-dependent phospholipase A2 inhibitor | 0.013 0.008 CID_59846969 | CID_59846969 | |
| 0.004 | 0.332 | 0.035 | Diamine oxidase inhibitor | 0.035 0.03 CID_59846969 | CID_59846969 | |
| 0.01 | 0.379 | 0.046 | Plasminogen activator inhibitor antagonist | 0.046 0.038 CID_59846969 | CID_59846969 | |
| 0.034 | 0.462 | 0.247 | Interleukin 1 antagonist | 0.247 0.019 CID_59846969 | CID_59846969 | |
| 0.016 | 0.787 | 0.296 | Toll-Like receptor 7 agonist | 0.296 0.112 CID_59846969 | CID_59846969 | |
| 0.014 | 0.794 | 0.282 | Toll-Like receptor agonist | 0.282 0.123 CID_59846969 | CID_59846969 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |